Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Tallman

Showing results (1-10 of 97) with videos related to

Pageof 10
Sort By:
Leukemia|August 1, 1996
Differentiating therapy in acute myeloid leukemiaM S Tallman
Leukemia|April 1, 1996
Differentiating therapy with all-trans retinoic acid in acute myeloid leukemiaM S Tallman
Leukemia|June 1, 1996
Differentiating therapy in acute myeloid leukemiaM S Tallman
Seminars in Thrombosis and Hemostasis|June 5, 1999
The thrombophilic state in acute promyelocytic leukemiaM S Tallman
Leukemia|October 20, 1998
Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyondM S Tallman
Seminars in Hematology|October 1, 1994
All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignanciesM S Tallman
Southern Medical Journal|March 1, 1985
Hereditary sensory neuropathy with macular dystrophyM S Tallman, M Levy
Journal of Clinical Pharmacology|October 1, 1992
Retinoids in cancer treatmentM S Tallman, P H Wiernik
Cancer Chemotherapy and Pharmacology|September 28, 1998
High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancerM S Tallman, W J Gradishar
Current Cancer Drug Targets|April 10, 2012
Novel and emerging drugs for acute myeloid leukemiaE M Stein, M S Tallman
Pageof 10

Showing results (1-10 of 97) with videos related to

Sort By:
Pageof 10
Leukemia|August 1, 1996
Differentiating therapy in acute myeloid leukemiaM S Tallman
Leukemia|April 1, 1996
Differentiating therapy with all-trans retinoic acid in acute myeloid leukemiaM S Tallman
Leukemia|June 1, 1996
Differentiating therapy in acute myeloid leukemiaM S Tallman
Seminars in Thrombosis and Hemostasis|June 5, 1999
The thrombophilic state in acute promyelocytic leukemiaM S Tallman
Leukemia|October 20, 1998
Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyondM S Tallman
Seminars in Hematology|October 1, 1994
All-trans-retinoic acid in acute promyelocytic leukemia and its potential in other hematologic malignanciesM S Tallman
Southern Medical Journal|March 1, 1985
Hereditary sensory neuropathy with macular dystrophyM S Tallman, M Levy
Journal of Clinical Pharmacology|October 1, 1992
Retinoids in cancer treatmentM S Tallman, P H Wiernik
Cancer Chemotherapy and Pharmacology|September 28, 1998
High-dose chemotherapy and autologous stem cell transplantation as treatment for high-risk breast cancerM S Tallman, W J Gradishar
Current Cancer Drug Targets|April 10, 2012
Novel and emerging drugs for acute myeloid leukemiaE M Stein, M S Tallman
Pageof 10